Snowball logo
logo
ATRA_logo

Atara Biotherapeutics, Inc

ATRA β€’ NASDAQ
$9.46-$0.24Β  (2.47%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
20.3463.578.573128.9120.823.14
COGS
11.382708.88621.0121.210.897
Gross Profit
20.34(206.4)(0.313)107.999.5622.24
Operating Expenses & Income
Operating Income
(340.5)(280.5)(276)(83.44)35.86(6.309)
Total Operating Expenses
360.874.1275.7191.463.728.55
R&D Expenses
282272.5224.8151.537.4510.62
Selling General & Admin Expenses
78.868.1350.9139.8926.2517.8
Earnings from Continuing Operations
Interest Expense
(9.712)(0.373)(5.285)(4.615)(3.792)(3.605)
Interest Income
0.3671.9864.7972.110.6830.501
Income Tax Expense
0.0460.0120.015(0.012)0.0310.031
Net Income
Net Income
(340.1)(228.3)(276.1)(85.4)32.69(9.467)
Supplemental
EBIT
(340.5)(227.9)(270.8)(80.8)36.51(5.831)
EBITDA
(331.1)(222.3)(266)(75.75)38.63(5.481)
In millions of USD, except % and values per 1 share